Abstract:

As the pandemic was sudden and no time was given to prepare for the lockdown measure, pharmaceutical practices were significantly disrupted in the aspects of manufacturing and supplying drugs, sales, and profit-making. Therefore, this study assessed the impacts of COVID-19 crisis on pharmaceutical practices in Nigeria. A descriptive cross-sectional design survey was adopted to draw information from the pharmacists (respondents) among the targeted population. 1,200 professional and practice pharmacists were systematically and randomly selected across the six geopolitical zones in Nigeria, while 1,118 copies of the administered questionnaire were retrieved, coded, and analyzed using descriptive and inferential statistics aided by the Statistical Package for Social Sciences (SPSS) software version 23 to run the analyses. The findings showed that COVID-19 had negative impacts on pharmaceutical practices, especially in hospital and community practices. A 25%-49% decrease was highly indicated in sales, purchase orders, and profits, while the majority, 347 (31.04%) of the respondents, indicated that they had a 1%-24% decrease in their workforce. Also, total lockdown as a COVID-19 measure increased the level of insecurity and inflation during the pandemic. 75.13% of the pharmacists who represent the targeted population indicated that their place of work largely enforced COVID-19 basic preventive measures during the pandemic. This study concludes that necessary efforts should be put in place to ease the affairs of the pharmaceutical practices before, during, and after the pandemic.
Keywords: COVID-19, Impact, Lockdown, Pharmaceutical Care, Practices, Nigeria.

References:

[1] Lai, J., Ma, S., Wang, Y., Cai, Z., Hu, J., Wei, N., et al. 2020, Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open, 3:e203976.

Doi:10.1001/ jamanetworkopen.2020.3976.

[2] World Health Organization, 2020, Coronavirus disease (COVID-19) Pandemic 2020. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed: 8 September 2021.

[3] World Health Organisation, 2021, COVID-19 report cases.

http://www.who.int/gho/countries/nga.pdf?ua=1.

[4] WHO, 2020, Middle East respiratory syndrome coronavirus (MERS-CoV). Available: https://www.who.int/emergencies/mers-cov/en/ Accessed: 8 September 2021.

[5] WHO, 2020, Severe Acute Respiratory Syndrome (SARS). Available: https://www.who.int/csr/sars/en/ Accessed: 7 September 2021.

[6] The Lancet, 2020, COVID-19: protecting health-care workers. Lancet. 395:922. doi:10.1016/S01406736(20)30644-9.

[7] Fatjona et aL. 2021, Impact of COVID-19 pandemic on mental health, risk perception and coping strategies among health care workers in Albania - evidence that needs attention. Clinical Epidemiology and Global Health, 12(2021)100824, 1-7. https://doi.org/10.1016/j.cegh.2021.100824.

[8] Lucero-Prisno, D.E., Adebisi, Y.A., and Lin, X., 2020, Current efforts and challenges facing responses to 2019-nCoV in Africa. Glob Health Res Policy, 5, 21. https://doi.org/10.1186/s41256-020-00148-1.

[9] WHO, 2020, Mental health and psychosocial considerations during the COVID-19 outbreak. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf?sfvrsn=6d3578af_2;2020.

[10] Zhu, N., Zhang, D., Wang, W., et al., 2020, A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017.

[11] Roy, R.M. et al. 2021, Psychological distress during pandemic Covid-19 among adult general population: Result across 13 countries. Clinical Epidemiology and Global Health, 10 (2021), 100708, 1-6.

https://doi.org/10.1016/j.cegh.2021.100708.

[12] Scherbina, B., 2020, Determining the optimal duration of the COVID-19 suppression policy: A cost-benefit analysis. AEI Economics Working Paper 2020-03. American Enterprise Institute, 1-28.

[13] Akande-Sholabi, W., Adebisi, Y.A., Bello, A., and Ilesanmi, O.S., 2020, COVID-19 in Nigeria: Is the pharmaceutical sector spared? Public Health in Practice, 1, 100044. https://doi.org/10.1016/j.puhip.2020.100044.

[14] David, K.B., and Adebisi, Y.A., 2020, Proposed model for hospital and community pharmacy services during COVID-19 pandemic in Nigeria. Int J Pharm Pract, 28, 544-545.

[15] Mila, N.N.H., Roy, R.M., Ayesha, A., Fatjona, K., Radwa, A.E., Jeldah, M.N., and Adinegara, L.A., 2020, Immediate impact of COVID-19 on mental health and its associated factors among healthcare workers: A global perspective across 31 countries. Viewpoints, 10(2), 020381, 1-6. doi: 10.7189/jogh.10.020381.

[16] Wagner, E.H., 1998, Chronic disease management: What will it take to improve care for chronic illness? Efficient Clinical Practice, 1(1), 2-4.

[17] Thomson, L.A., et al., 2007, Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy, 41(9), 1411-1426.

[18] Shanmugam, S., et al., 2011, Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. Journal of Royal Medical Society, 16(1), 412-418.

[19] Anyama, N., and Adome, R.O., 2003, Community pharmaceutical care: An 8-month critical review of two pharmacies in Kampala. African Health Sciences, 3(2), 87-93.

[20] Dunlop, J.A., and Shas, J.P., 2002, Pharmacist’s perspective on pharmaceutical care implementation in New Zealand. Pharmacy World and Science, 24(6), 224-30.

[21] Gloria, N., and Sylvie, P., 2000, Optimizing adherence to pharmaceutical care plan. Journal of American Pharmaceutical Association, 40(4), 475-482.

[22] Erah, P.O., and Nwazuoke, J.C., 2002, Identification of standards for pharmaceutical care in Benin City. Tropical Journal of Pharmaceutical Research, 1(2), 55-66.

[23] Oparah, C.A., and Eferakeya, A.E, 2005, Attitude of Nigerian pharmacists towards pharmaceutical care. Pharmacy World and Science, 27(3), 208-214.

[24] Salami, A.A., 2018, Assessment of remote sensing in deriving meteorological data for agricultural purposes in Nigeria. A Ph.D. proposal presented at the department of Geography and Environmental Management, University of Ilorin, Nigeria.

[25] Salami, A.A., Olorunfemi, J.F., and Olanrewaju, R.M., 2020, Geo-spatial analysis of rainfall amounts and rainy days using satellites and ground-based data in Nigeria. Journal of Meteorology and Climate Science, 18 (1).

[26] National Population Commission, 2016, 2016 Projected population of Federal Republic of Nigeria 2006 Population and Housing Census, Priority Tables, Vol. VII Abuja, Nigeria.

[27] Eze, T.C., Okpala, C.S., and Ogbodo, J.C., 2014, Patterns of inequality in human development across Nigeria’s six geopolitical zones. J Dev Ctries Stud., 4(8), 97–101.

[28] World Health Organization, 2015, Nigeria: World Health Organisation statistical profile 2015. Available from: http://www.who.int/gho/countries/nga.pdf?ua=1.

[29] Ekpenyong, A., Udoh, A., Kpokiri, E., and Bates, I., 2018, An analysis of pharmacy workforce capacity in Nigeria. Journal of Pharmaceutical Policy and Practice, 11:20. https://doi.org/10.1186/s40545-018-0147-9.

[30] Ashiru-Oredope, D., Chan, A.H.Y., Olaoye, O., Rutter, V., Babar, Z. and the C.P.A. COVID-19 Action Team, 2020, Needs assessment and impact of COVID-19 on pharmaceutical professionals in 31 commonwealth countries. J of Pharm Policy and Pract 13, 72, 1-11. https://doi.org/10.1186/s40545-020-00275-7.

[31] Smith, A.J., Scahill, L.S., Harrison, J., Carroll, T., and Medlicott, J.N., 2018, Service provision in the wake of a new funding model for community pharmacy. BMC Health Services Research, 18, 2-10. https://doi.org/10.1186/s12913-018-3120-z.

[32] Ayati, N., Saiyarsarai, P., Nikfar, S., 2020-, Short- and long-term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, 28, 799–805. https://doi.org/10.1007/s40199-020-00358-5.

[33] Miles, S.H., Kaci, H., 2015, Public health and the politics of fear. Am J Bioeth. 15(4), 17–19. https://doi.org/10.1080/15265161.2015.1010994.

[34] Yoon, M.K., Kim, S.Y., Ko, H.S., Lee, M.S., 2016, System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: A case report of community-based proactive intervention in South Korea. Int J Ment Health Syst. 10:51. https://doi.org/10.1186/s13033-016- 0083-5.

[35] Marzo, R.R., Singh, A., Mukti, R.F., 2021, A survey of psychological distress among Bangladeshi people during the COVID-19 pandemic. Clinical Epidemiology and Global Health. 10:1016. https://doi.org/10.1016/j.cegh.2020.100693.

[36] Htay, M.N.N., Marzo, R.R., AlRifai, A. et al., 2020, Immediate impact of COVID-19 on mental health and its associated factors among healthcare workers: a global perspective across 31 countries. J Glob Health. 2020;10, 020382. https://doi.org/10.7189/jogh.10.020381.

[37] Brooks, S.K., Webster, R.K., Smith, L.E., et al., 2020, The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet., 395(10227), 912–920. https://doi.org/10.1016/S0140-6736(20)30460-8.

[38] Nilima, N., Kaushik, S., Tiwary, B., Pandey, P.K., 2021, Psycho-social factors associated with the nationwide lockdown in India during COVID- 19 pandemic. Clin Epidemiol Glob Health, 9, 47-52.

[39] Lai, J., Ma, S., Wang, Y., Cai, Z., Hu, J., Wei, N., et al. 2020, Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 3(3), e203976.

[40] Bohlken, J., Schömig, F., Lemke, M.R., Pumberger, M., Riedel-Heller, S.G., 2020, COVID-19 Pandemic: Stress Experience of Healthcare Workers - A Short Current Review. Psychiatr Prax., 47(4),190-7.

[41] Watson, M.C., Silver, K., and Watkins, R., 2019, How does the public conceptualise the quality of care and its measurement in community pharmacies in the UK: A qualitative interview study. BMJ Open, 9e027198, 1-7. Doi: 10.1136/bmjopen-2018-027198.

[42] Bukhari, N., Rasheed, H., Nayyer, B., and Babar, Z., 2020, Pharmacists at the frontline beating the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice, 13, (8), 1-4. https://doi.org/10.1186/s40545-020-00210-w.

[43] Chukwuorji J.C., and Iorfa, S.K., 2020, Commentary on the coronavirus pandemic: Nigeria. Psychological Trauma: Theory, Research, Practice, and Policy, 12(S1), S188– S190. DOI 10.1037/tra0000786.

[44] Dkhar, S.A., Quansar, R., Saleem, S.M. and Khan, S.M., 2020, Knowledge, attitude, and practices related to COVID‐19 pandemic among social media users in J&K, India. Indian Journal of Public Health, 64(6), 205–210 DOI 10.4103/ijph.IJPH_469_20.

[45] Ilesanmi, O., and Afolabi, A., 2020, Perception and practices during the COVID-19 pandemic in an urban community in Nigeria: A cross-sectional study. PeerJ8:e10038. DOI 10.7717/peerj.10038.

[46] Iorfa, S.K., Ottu, I.F.A., Oguntayo, R., Ayandele, O., Kolawole, S.O., Gandi, G.C., Dangiwa, A.L., and Olapegba, P.O., 2020, COVID-19 knowledge, risk perception and precautionary behavior among Nigerians: A moderated mediation approach. medRxiv DOI 10.1101/2020.05.20.20104786.

[47] Zhong, B-L, Luo, W., Li, H-M., Zhang, Q-Q., Liu, X-G., Li, W-T., and Li, Y., 2020, Knowledge, attitudes and practices towards COVID19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey. International Journal of Biological Sciences, 16(10), 1745–1752 DOI 10.7150/ijbs.45221.

[48] WHO, 2020b, Coronavirus disease (COVID-19) situation report-149 Geneva: World Health Organization. Accessed: 26 August 2020. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200623-covid-19-sitrep-155.pdf?sfvrsn=ca01ebe_2.

[49] Al-Hanawi, M.K., Angawi, K., Aishareel, N., Qattan, A.M.N., Helmy, H.Z. … Aisharqi, O., 2020, Knowledge, attitude and practice toward COVID-19 among the public in the Kingdom of Saudi Arabia: A cross-sectional study. Front. Public Health, 8, 217, 1-10. Doi:10.3389/fpubh.2020.00217.

[50] Witte, K., 1998, Fear as motivator, fear as inhibitor: using the extended parallel process model to explain fear appeal successes and failures. In Andersen, P.A. and Guerrero L.K., (Eds), The Handbook of Communication and Emotion: Research, Theory, Applications, and Contexts (pp. 423–450), San Diego: Academic.

[51] Nabi, R.L., 1999, A cognitive-functional model for the effects of discrete negative emotions on information processing, attitude change, and recall. Communication Theory, 9(3), 292–320. DOI 10.1111/j.1468-2885. 1999. Tb00172. x.

[52] Ufuwa, I.S., Akpa, C.O., Umeokonkwo, C.D., Umoke, M., Oguanuo, C.S., Olorukooba, A.A., Bamgboye, E., and Balogun, M.S., 2020, Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: Implications for risk communication. BMC Public Health, 20(1), 1–10. DOI 10.1186/s12889-020-8299-3.